Pathology lab group APHG, reportedly lined up for purchase by the NZ Super Fund, has reported another bumper profit for the year to June 2019, enabling payment of a $55 million dividend to its private equity owner.
APHG owns most of the path labs in the country, including Labtests Auckland,
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
